Who has invested in Bicara Therapeutics?

Eight Roads are named among the investors backing Bicara Therapeutics.

Bicara Therapeutics Funding: $165M Raised, Series C (2024)

Bicara Therapeutics funding overview

Bicara Therapeutics is based in Boston. Bicara Therapeutics has raised $165M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2024. The round record for Bicara Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Eight Roads.

Bicara Therapeutics at a glance

Total raised: $165M
Latest round: Series C
Latest round date: September 2024
Headquarters: Boston
Notable investors: Eight Roads

Frequently asked about Bicara Therapeutics funding

How much has Bicara Therapeutics raised?: Bicara Therapeutics has raised $165M in total disclosed funding across the rounds on record.
Who has invested in Bicara Therapeutics?: Eight Roads are named among the investors backing Bicara Therapeutics.
What was the latest Bicara Therapeutics funding round?: The most recent disclosed round is a Series C, announced in September 2024.
Where is Bicara Therapeutics based?: Bicara Therapeutics is based in Boston.
When did Bicara Therapeutics last raise?: The last disclosed Bicara Therapeutics round closed in September 2024 at Series C.

Totals shown for Bicara Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.

Bicara Therapeutics Funding: $165M Raised, Series C (2024)

Bicara Therapeutics funding overview

Bicara Therapeutics at a glance

Frequently asked about Bicara Therapeutics funding

Companies related to Bicara Therapeutics (36)

Browse related funding lists (6)